Your browser doesn't support javascript.
loading
In response to the comment by Hechler et al.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance.
Stivala, Simona; Gobbato, Sara; Infanti, Laura; Reiner, Martin F; Bonetti, Nicole; Meyer, Sara C; Camici, Giovanni G; Lüscher, Thomas F; Buser, Andreas; Beer, Juerg H.
Afiliação
  • Stivala S; Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland.
  • Gobbato S; Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland.
  • Infanti L; Regional Service of the Swiss Red Cross, University Hospital Basel, Switzerland.
  • Reiner MF; Internal Medicine, Cantonal Hospital of Baden, Switzerland.
  • Bonetti N; Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland.
  • Meyer SC; Hematology, University Hospital Basel, Switzerland.
  • Camici GG; Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland.
  • Lüscher TF; Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland.
  • Buser A; Regional Service of the Swiss Red Cross, University Hospital Basel, Switzerland.
  • Beer JH; Laboratory for Platelet Research, Center for Molecular Cardiology, University of Zurich, Switzerland juerg-hans.beer@ksb.ch.
Haematologica ; 102(12): e504-e505, 2017 12.
Article em En | MEDLINE | ID: mdl-29192132

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Furocumarinas / Plaquetas Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Furocumarinas / Plaquetas Idioma: En Ano de publicação: 2017 Tipo de documento: Article